HFE hemochromatosis: an overview about therapeutic recommendations
Cancado, Rodolfo D; Alvarenga, Aline Morgan; Santos, Paulo Caleb J. L.
Hematol., Transfus. Cell Ther. (Impr.)
; 44(1): 95-99, Jan.-Mar. 2022. tab
Artículo
en Inglés
| LILACS | ID: biblio-1364881
Abstract Hemochromatosis is currently characterized by the iron overload caused by hepcidin deficiency. Large advances in the knowledge on the hemochromatosis pathophysiology have occurred due to a better understanding of the protein of the iron metabolism, the genetic basis of hemochromatosis and of other iron overload diseases or conditions which can lead to this phenotype. In the present review, the main aims are to show updates on hemochromatosis and to report a practical set of therapeutic recommendations for the human factors engineering protein (HFE) hemochromatosis for the p.Cys282Tyr (C282Y/C282Y) homozygous genotype, elaborated by the Haemochromatosis International Taskforce.
Biblioteca responsable:
BR408.1
Ubicación: BR408.1
Texto completo
Documentos relacionados